stockportfolio.pro
Gilead Sciences, Inc. Net Income 2007–2025
Gilead Sciences, Inc. (GILD) annual net income by fiscal year, computed from SEC filings. Compound growth +9.8%/yr over 18 years.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $8.51B | 28.9% | +1672.9% |
| FY 2024 | $480.00M | 1.7% | -91.5% |
| FY 2023 | $5.67B | 20.9% | +23.4% |
| FY 2022 | $4.59B | 16.8% | -26.2% |
| FY 2021 | $6.22B | 22.8% | +4961.0% |
| FY 2020 | $123.00M | 0.5% | -97.7% |
| FY 2019 | $5.39B | 24.0% | -1.3% |
| FY 2018 | $5.46B | 24.7% | +17.9% |
| FY 2017 | $4.63B | 17.7% | -65.7% |
| FY 2016 | $13.50B | 44.4% | -25.4% |
| FY 2015 | $18.11B | 55.5% | +49.6% |
| FY 2014 | $12.10B | 48.6% | +293.5% |
| FY 2013 | $3.08B | 27.5% | +18.6% |
| FY 2012 | $2.59B | 26.7% | -7.5% |
| FY 2011 | $2.80B | 33.4% | -3.4% |
| FY 2010 | $2.90B | 36.5% | +10.1% |
| FY 2009 | $2.64B | 37.6% | +33.2% |
| FY 2008 | $1.98B | 37.1% | +24.9% |
| FY 2007 | $1.58B | 37.5% | — |
Source: Gilead Sciences, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Gilead Sciences, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeGilead Sciences, Inc. — frequently asked questions
What is Gilead Sciences, Inc.'s net income?
Gilead Sciences, Inc. (GILD) reported net income of $8.51B for fiscal year 2025, per its SEC filings.
How has Gilead Sciences, Inc.'s net income changed over time?
Between fiscal 2007 and 2025, GILD's net income grew at roughly 9.8% per year (compound annual rate), from $1.58B to $8.51B.
Where does this data come from?
Figures are computed from Gilead Sciences, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.